8-K/A XBRL

8-K/A

Company: SUPERNUS PHARMACEUTICALS, INC.
Filed: August 10, 2023
Period of Report: August 8, 2023
Accession Number: 0001356576-23-000053

View Document ↗ View on SEC.gov ↗